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Abstract
Purpose This systematic review determined the reported treatment strategies, their individual success rates, and other 
outcome parameters in the management of critical-sized bone defects in fracture-related infection (FRI) patients between 
1990 and 2018.
Methods A systematic literature search on treatment and outcome of critical-sized bone defects in FRI was performed. 
Treatment strategies identified were, autologous cancellous grafts, autologous cancellous grafts combined with local anti-
biotics, the induced membrane technique, vascularized grafts, Ilizarov bone transport, and bone transport combined with 
local antibiotics. Outcomes were bone healing and infection eradication after primary surgical protocol and recurrence of 
FRI and amputations at the end of study period.
Results Fifty studies were included, describing 1530 patients, the tibia was affected in 82%. Mean age was 40 years (range 
6–80), with predominantly male subjects (79%). Mean duration of infection was 17 months (range 1–624) and mean follow-up 
51 months (range 6–126). After initial protocolized treatment, FRI was cured in 83% (95% CI 79–87) of all cases, increas-
ing to 94% (95% CI 92–96) at the end of each individual study. Recurrence of infection was seen in 8% (95% CI 6–11) and 
amputation in 3% (95% CI 2–3). Final outcomes overlapped across treatment strategies.
Conclusion Results should be interpreted with caution due to the retrospective and observational design of most studies, 
the lack of clear classification systems, incomplete data reports, potential underreporting of adverse outcomes, and hetero-
geneity in patient series. A consensus on classification, treatment protocols, and outcome is needed to improve reliability 
of future studies.
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Introduction
Segmental bone loss after trauma remains a challenging 
problem for orthopedic trauma surgeons. When a bone 
defect exists combined with fracture-related infection (FRI), 
the chances of successful bone consolidation and clearance 
of infection are reduced.
A ‘critical-sized’ defect is a bone defect which is not 
expected to heal in the absence of a secondary (surgical) 
intervention. There is no agreed definition of what consti-
tutes a critical defect in humans. Court-Brown defined it [1] 
as a defect involving 50% of the cortical diameter with a 
minimum length of 1 cm, and this was used in the Study to 
Prospectively evaluate Intramedullary Nails in Tibial frac-
tures (SPRINT) [2]. A study by Sanders et al. [3] showed 
that, when using this definition, 47% of the bone defects 
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healed without additional surgery, thus indicating that these 
are not always critical defects. When infection is present, it 
is much less likely that the fracture will heal [4, 5], so in this 
analysis, The SPRINT definition for a critical-sized defect 
in FRI was accepted.
Over the past decades, critical-sized bone defects in FRI 
have been treated using different protocols. Techniques used 
(e.g., Ilizarov, Papineau, Masquelet, or RIA) all have differ-
ent indications and success rates, resulting in a wide range 
of clinical outcomes. The aim of this systematic review and 
pooled analysis was to evaluate identified treatment strate-
gies, their individual success rates and other outcome param-
eters regarding critical-sized bone defects used between 
1990 and 2018.
Methods
Literature search strategy
A literature search was completed with the help of a bio-
medical information specialist on June 25, 2018, using 
Medline, Embase, Web of Science, Cochrane, and Google 
Scholar. The search strings are provided in Appendix 1. 
Studies that described treatment of FRI using autologous 
cancellous grafts, autologous cancellous grafts combined 
with local antibiotics, the induced membrane technique, 
vascularized grafts, bone transport, and bone transport 
combined with local antibiotics were included. Series 
needed to be greater than five patients, reported in English, 
and bone defects described as ≥ 1 cm. Studies that did not 
describe FRI patient treatment and publications reporting 
non-original data (e.g., reviews or meta-analyses), or those 
published before 1990, were excluded. Inclusion was agreed 
by two independent reviewers, HB an LWV, and consisted 
of two phases. During the first phase, title and abstract were 
screened for relevance and full text articles were obtained. 
When possible, full texts that were not available, were 
obtained by contacting the corresponding author once by 
email. The second phase consisted of reviewing the full text 
articles. Consensus was reached on all references. This study 
was performed using the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses (PRISMA) criteria [6].
Data extraction
Data from each included study were extracted by two authors 
independently (HB an LWV). Disagreements were discussed 
until agreement was reached. Data were collected in three 
areas.
1. General information of all studies (i.e., sample size, age, 
FRI, and location of FRI).
2. Data from surgical protocols (i.e., number of stages in 
surgical protocol, bone defect size, type of bone graft 
and type of fixation used).
3. Clinical outcomes (bony consolidation without infection 
after the primary surgical protocol, bony consolidation 
without infection after the study period, recurrence of 
FRI, amputation of the affected limb, number of com-
plications, revision surgery, time to bony union, and 
Length of Hospital Stay (LOHS).
Analysis
A quality assessment of all included studies was done 
according to the revised and validated versions of MINORS 
[7]. Results for the total population were pooled and pre-
sented separately for each of the six different treatment 
strategies. Medcalc (MedCalc Statistical Software version 
17.9.7, MedCalc Software bvba, Ostend, Belgium; http://
www.medca lc.org; 2017) was used for pooling binominal 
data. Heterogeneity was quantified using the Cochran’s Q 
test and I2 statistic. When I2 was < 40%, a fixed effects model 
was used, and a random effects model, when I2 was ≥ 40%. 
Pooled estimates are reported with their 95% confidence 
intervals (CI). Publication bias was assessed from funnel 
plots for each clinical outcome and per treatment type sepa-
rately. The majority of studies only provided a mean but not 
the standard deviation. Thus, a full meta-analysis for con-
tinuous data was not feasible. Continuous data were pooled 
by calculating the weighted mean using Microsoft Excel. 
Sample size of the individual studies was used as weighting 
factor. The pooled mean is reported with the range.
Results
General population demographics
After selection, 43 studies [8–50] were included describing 
50 patient series in the treatment of FRI with bone defects of 
≥ 1 cm (Fig. 1). In these studies, 1530 patients with FRI were 
treated, with a mean bone defect of 6.6 cm (range 1.0–26.0), 
of which 1253 (82%) were localized at the tibia. The popu-
lation had a mean age of 40 years (range 6–80), with 1176 
(79%) male patients and a mean duration of infection of 
17 months (range 1–624). Mean follow-up was 51 months 
(range 6–126). Study characteristics and quality assessment 
according to the MINORS score are given in appendix 2. 
The type of bone grafts used are depicted in Table 1.
Nine series (18%) described treatment of bone defects by 
cancellous grafts alone and nine series (18%) by the use of a 
cancellous graft in combination with local antibiotics, either 
beads or an antibiotic rod. The induced membrane technique 
was described in eight (16%) series, and treatment with a 
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vascularized bone graft was used in four series (8%). Bone 
transport alone was used in 15 series (30%), and bone trans-
port in combination with local antibiotic beads in 5 (10%).
Description by treatment type
Table 2 summarizes the population of all treatment types and 
Table 3 explains all different surgical stages. 
Cancellous grafts (with or without local antibiotics)
In 18 studies [9–11, 15, 17, 18, 22, 24, 26, 32–36, 38, 42, 
44, 49] (36%), a total of 472 (31%) patients were treated 
with a cancellous bone graft, half of these studies used a 
cancellous graft only, the other half used a cancellous bone 
graft after local antibiotics treatment with either Polymethyl 
methacrylate (PMMA) beads or a cement rod.
The 9 studies (18%) describing treatment with a cancel-
lous graft only included 311 (20%) patients, with a mean age 
of 40 years (range 16–68) and a mean bone defect of 4.6 cm 
(range 1–16). Four studies (44%), used a one-stage recon-
struction, three studies (33%) a two-stage, and one study 
Fig. 1  Inclusion flowchart
Table 1  Bone grafts used in treatment of bone defects
BMP bone morphogenetic protein, N total number of bone grafts 
used, RIA reamer irrigator aspirator
Type used in total (50 patient series) N = 1063 (% of total)
Non-vascularized cancellous bone 639 (60%)
 Iliac crest 600 (56%)
  With granulocytes 139
  With BMP-7 10
 RIA 39 (4%)
  With BMP-7 37
Vascularized bone 324 (30%)
 Fibula 260 (25%)
 Latissimus Dorsi with rib 41 (4%)
 Ilium 18 (2%)
 Scapula 5 (1%)
Other
 Mesenchymal stem cells 15 (1%)
Graft not defined 70 (6%)
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(11%) a three-stage. One study (11%) did not describe the 
number of stages.
The other 9 studies (18%), which used a cancellous graft 
after placement of PMMA beads or a cement rod, described 
the treatment of 161 (11%) patients. The mean patient age 
was 37 years (range 18–79) and the mean bone defect length 
was 4.9 cm (range 1–12). The majority, 67%, were treated 
by a two-stage protocol, two studies (22%) used a three-
stage protocol and one (11%) did not mention the number 
of stages. Mean time between placement and removal of the 
antibiotic carrier was 31 days.
Induced membrane technique
Eight series [23, 29, 30, 34, 37, 40, 43, 48] (16%) described 
the treatment of 177 (12%) patients, with a mean age of 
42 years (range 16–72), a mean bone defect size of 4.5 cm 
(range 1.0–26.0), that were followed-up for a mean of 
26 months (range 13–72). All eight studies used a two-stage 
reconstruction protocol with an antibiotic loaded cement 
spacer, which was removed after a mean time of 68 days.
Table 2  Study characteristics
Age; FU follow-up; and defect size are depicted by mean (range); AB antibiotics
Overall Series (N) Patients (N) Age (years) FU (months) Defect size (cm)
50 1530 40 (6–80) 51 (6–126) 6.6 (1–26)
Surgical protocol
 Cancellous graft only 9 311 40 (16–68) 61 (10–120) 4.6 (1–16)
 Cancellous graft with AB 9 161 37 (18–79) 43 (24–126) 4.9 (1–12)
 Induced membrane 8 177 42 (16–72) 26 (13–72) 4.5 (1–26)
 Vascularized graft 4 322 43 (6–69) 75 (6–86) 10.7 (1–21)
 Bone transport only 15 395 37 (17–80) 34 (12–106) 5.5 (1–21)
 Bone transport with AB 5 164 43 (15–68) 49 (12–102) 5.7 (3–14)
Table 3  Surgical stages 
explained
AB antibiotics, Debr debridement, CBG cancellous bone graft, STC soft tissue coverage, AB antibiotics, 
def. fix. definitive fixation, VBG vascularized bone graft
Surgical protocol (series) Stage description [References]
Cancellous graft only [9]
 One stage [4] Debr. CBG [15, 18, 22, 42]
 Two stage [3] Debr. delayed CBG [26, 36, 44]
 Three stage [1] Debr. delayed CBG, delayed STC [33]
Cancellous graft with AB [9]
 Two stage [6] Debr. local AB, delayed CBG and def. fix [10, 24, 32, 34, 35, 38]
 Three stage [2] Debr. two times local AB, delayed CBG and def. fix [11]
Debr. local AB, delayed STC, delayed CBG and def. fix [49]
Induced membrane [8]
 Two stage [8] Debr. local AB, delayed CBG and def. fix. [23, 29, 30, 34, 37, 40, 43, 48]
Vascularized graft [4]
 One stage [2] Debr. VBG [16, 46]
 Two stage [1] Debr. local AB, VBG [41]
Bone transport only [15]
 One stage [12] Debr. Ilizarov application [8, 14, 25–28, 36, 38, 39, 47, 50]
 Three stage [1] Debr. delayed tibia osteotomy, arthrodesis ankle [12]
Bone transport with AB [5]
 One stage [1] Debr. CaSO4 AB pellets, Ilizarov application [40]
 Two stage [4] Debr. local AB, delayed Ilizarov application [13, 18, 20, 31]
Unspecified [5] [9, 17, 19, 21, 45]
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Vascularized grafts
In four (8%) studies [16, 21, 41, 46], a total of 322 (21%) 
patients were treated with a vascularized bone graft all using 
mixed, internal and external, fixation protocols. Two stud-
ies (50%) used a single-stage procedure, one study (25%) a 
two-stage procedure, and one study (25%) did not describe 
the number of stages. Their mean patient age was 43 years 
(range 6–69), with a mean defect size of 10.7 cm (range 
1.0–21.0), and a mean follow-up of 75 months (range 6–86).
Bone transport
In 20 studies [8, 12–14, 18–20, 25–28, 31, 36, 38–40, 45, 
47, 50] (40%), 559 (37%) patients were treated using a bone 
transport technique. In 15 (75%) of these studies, bone trans-
port was used without the use of local antibiotic therapy. 
These series described the treatment of 395 (26%) patients 
with FRI, with a mean age of 37 years (range 17–80), and a 
mean defect length of 5.5 cm (range 1–21). Twelve studies 
(80%) mentioned a one-stage bone transport procedure, one 
(2%) described a three-stage bone transport procedure with 
open wound treatment, and two (4%) did not mention the 
number of stages.
The remaining five studies (26%) used a combination 
of bone transport and local antibiotics to treat 164 (11%) 
patients, aged 43 years (range 15–68), with a mean bone 
defect of 5.7 cm (range 3–14). All studies used local antibi-
otics in the form of beads, four studies (80%) used PMMA as 
a carrier in a two-stage design, and one (20%) used calcium 
sulphate pellets in a one-stage protocol. Mean time before 
removal of the PMMA beads was 42 days.
Clinical outcome of all studies
After initial protocolized treatment, FRI was cured and bone 
defects healed in 83% (95% CI 79–87) of all cases, increas-
ing to 94% (95% CI 92–96) with further treatment, at the 
end of the total study period. Recurrence of infection was 
seen in 8% (95% CI 6–11), and amputation in 3% (95% CI 
2–3) of all cases.
Figure 2 shows the clinical outcome for all studies. Final 
outcomes overlapped across all different treatments. The use 
of the induced membrane or bone transport technique shows 
a trend of increased recurrence of infection when compared 
to the other techniques. Reconstruction with the induced 
membrane technique, a vascularized graft, or bone trans-
port with local antibiotics tends to lead to a larger amputa-
tion rate than the bone transport and two other cancellous 
graft treatments alone. Funnel plots assessing publication 
bias for each clinical outcome are presented per treatment 
type in Appendix 3. The funnel plots of primary and total 
healing both show comparable asymmetry, possibly due 
the smaller studies having worse outcome. Publication bias 
could have occurred because of different study size popula-
tions in mostly retrospective series underreporting negative 
outcomes. This could also be the case for the funnel plots 
depicting recurrence of infection and amputation ratio. Half 
of all studies do not report recurrence of infection, possibly 
due to better surgical protocols, or underreporting of nega-
tive clinical outcome in mostly retrospective series. Forest 
plots depicting clinical outcome per treatment type are given 
in Appendix 4.
Figure 3 shows the weighted means for all continuous 
outcomes. In 33 (66%) studies reporting time to union, bony 
union was achieved after a mean of 6.7 months. Patients 
were hospitalized for a mean of 1.7 months. A mean of 0.7 
complications per patients were recorded, i.e. superficial or 
deep infection, hemorrhage, deformities, and non-union. 
Almost one-third of all patients required at least one reop-
eration. Overall time to union, LOHS, complication rate per 
patient, and surgical revisions per patient could not be com-
pared between groups. The use of vascularized grafts tends 
to have a shorter time of union, number of complications 
and less necessary surgical revisions when compared to the 
other groups.
Discussion
Adequate debridement of non-viable bone remains one of 
the cornerstones of the management of FRI [51, 52]. This 
debridement, along with the bone loss that occurs at the time 
of the initial trauma and due to the infectious process itself, 
frequently results in the presence of significant bone defects 
in patients with FRI. The optimal management of these bone 
defects remains controversial, leading to the numerous tech-
niques described [53].
This systematic review revealed that the current most 
popular techniques resulted in comparable rates of healing 
and recurrence of infection. It is however unlikely that one 
reconstruction technique will be able to address all types of 
bone defects in FRI patients. Kadhim et al. [54] reviewed 
the use of bone transport or a vascularized bone graft for 
reconstruction of segmental bone defects, showing differ-
ent success rates at different anatomical locations. Other 
recent reports have raised concern with regards to the effi-
cacy of the induced membrane technique, for example, as a 
reconstruction technique of post-infective tibial shaft defects 
[30, 55, 56]. The need therefore is to determine what tech-
nique would be deemed optimal in a certain specific clinical 
scenario.
Due to several factors, it was not possible to draw firm 
conclusions from the data in this regard. Firstly, the het-
erogeneity of the patient populations made comparison of 
outcomes difficult. There was, for example, a difference in 
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the mean size of the defects among the different treatment 
groups. Series describing the use of vascularized grafts or 
bone transport techniques treated larger bone defects than 
series using cancellous grafts. Also, in studies describing a 
two-stage reconstruction protocol, often more surgical revi-
sions were performed than initially expected.
The choice of reconstruction technique depends on many 
factors. These include the host’s physiological status and 
ability to participate in the rehabilitation program, the shape 
and location of the defect, duration of the defect (i.e., acute/
early or chronic/late-onset), quality of the surrounding soft 
tissue, bone quality, the presence of deformity, adjacent joint 
contracture/instability or limb length discrepancy, as well 
as the experience of the surgeon [57]. Unfortunately, the 
published series do not always report the details of these 
factors. It is often impossible to understand how patients 
Fig. 2  Proportional clinical outcome. Numbers under the X-axis represent the number of studies for which data are pooled; AB local antibiotics
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were selected for a particular technique. This deficit makes 
comparison of outcomes difficult. The outcome of the use 
of one technique in compromised hosts with tibial defects, 
for example, cannot be compared with the results of another 
technique in optimized hosts in the upper limb.
Most studies provide a cohort of cases treated with a sin-
gle technique, rather than a consecutive series of patients, 
selected because of the characteristics of the disease [58]. 
This makes firm conclusions on the efficacy of a technique 
in a patient population impossible [59].
Secondly, of all included series, 12 (24%) [20, 23, 32, 33, 
35, 37, 40, 41, 43, 46, 47] describe FRI on multiple anatomi-
cal locations, and six (12%) [8, 12, 17, 38, 48] describe FRI 
of the femur, ankle or foot. Although these series are low in 
number of patients, data pooling still results in a distorted 
outcome.
Fig. 3  Clinical outcome by weighted mean. Numbers under the X-axis represent the number of studies for which data are pooled; AB local anti-
biotics
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The current lack of a universally accepted classifica-
tion system for both FRI and post-infective bone defects 
is evident in this systematic review. The need remains for 
the development of a pragmatic classification system that 
can be used, not only to guide treatment, but also to ade-
quately characterize the patient cohort for research pur-
poses [60–62]. Similarly, traditional classification systems 
for post-infective bone defects have failed to keep up with 
contemporary trends in reconstruction. The classification of 
post-infective tibial bone defects proposed by May and Jupi-
ter, for example, does not cater for the induced membrane 
technique [63].
In addition to the lack of an applicable classification of 
post-infective bone defects, a working definition of defects 
is needed which cannot be expected to heal without inter-
vention. While the difference between a stable cavitory 
(contained) defect and an unstable defect may be appar-
ent, there may be a need to further define critical unstable 
defects to investigate the outcomes of treatment modalities 
in different types of critical bone defects. This definition, 
together with a pragmatic classification would allow the 
development of a practical algorithm for management of 
these infected defects. It may be foreseen that a 4 cm conical 
(partial) humeral defect with 20% cortical bone contact may 
be treated differently than a 4 cm segmental (complete) tibial 
defect, for example [64].
In addition to the lack of uniformity in terms of patient 
population, numerous other factors prohibit direct compari-
son of results from the studies included in this systematic 
review. Due to the retrospective and observational nature of 
most studies, treatment strategy selection was not always 
clearly reported and may not have been consistent. Further-
more, data were not always sufficiently complete to allow 
comparison of outcomes. For continuous outcomes, most 
studies failed to report the standard deviation along with 
the mean value. Underreporting of adverse effects is of par-
ticular concern, especially if risks associated with a specific 
treatment option in a specific clinical setting should be taken 
into account when choosing a reconstructive option. When 
looking at the asymmetrical form of the funnel plots cre-
ated for all clinical outcomes, this could be the case, as is 
discussed above.
Mauffrey and Hak [55] have recently highlighted the lack 
of standardization in the management algorithms for tibial 
defect reconstruction, particularly in the setting of post-
infective defects where treatment strategy selection is often 
based on surgeon preference rather than scientific evidence 
[65]. Similarly, Makridis et al. [65] found great heterogene-
ity of studies in the field of FRI, which made the develop-
ment of evidenced-based management protocols difficult. 
The lack of comparative studies is also evident. While bone 
transport and the induced membrane technique remain two 
popular treatment options, there is no high-quality evidence 
indicating that one is superior to the other [66], or which 
patients are best suited to each technique. This systematic 
review confirmed that evidence to make any high-level rec-
ommendation with regard to the management of post-infec-
tive bone defects in FRI patients is currently insufficient.
It is unlikely that one single, high volume center is able to 
adequately study the problem of FRI. Even in such referral 
centers the number of patients treated in a reasonable time 
span is not sufficient to achieve enough statistical power to 
draw firm conclusions on current treatment standards and 
new therapeutic options. This implies that (international) 
collaboration is essential to be able to pool treatment results 
from individual hospitals into (prospective) clinical studies 
and subsequently into meaningful meta-analyses. Only then, 
can adequate progress in the treatment of FRI be made. To 
facilitate such a collaboration, uniform definitions for clas-
sification, diagnostic and treatment protocols and follow-up 
are required. The current meta-analysis clearly shows that 
the way in which data have been collected and reported in 
the past cannot inform best practice in the future.
Conclusions
This is the first extensive review of bone defect treatment 
protocols for FRI. Six individual treatment protocols for 
FRI treatment were identified, i.e., cancellous grafts with or 
without the use of local antibiotics, the induced membrane 
technique, the use of vascularized grafts, or the Ilizarov bone 
transport technique with or without the use of local antibiot-
ics. All show comparable outcome. Overall published work 
showed a high success rate of 94%, a recurrence rate of 8%, 
and low amputation rate of only 3%. However, data did not 
allow a reliable comparison across treatments, or a recom-
mendation on which treatment strategy is appropriate for 
any particular clinical scenario. The results should thus be 
interpreted with caution due to the retrospective design of 
most studies, the lack of clear classification systems, incom-
plete data reports, underreporting of adverse outcomes, and 
heterogeneity in patient series. Secondly, this review reveals 
the true scientific and clinical needs: uniform definitions on 
terms used, a consensus on classification, structured treat-
ment protocols, and clear outcome parameters are needed to 
improve reliability of future multicenter studies.
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Appendix 1: Search terms used 
for the individual databases
(A) Medline OVID: (“osteitis”/ OR “osteomyelitis”/ OR 
(osteitis OR osteomyelitis).ab,ti.) AND (exp “Fractures, 
Bone”/ OR (fracture* OR nonunion* OR malunion* OR 
nonunited* OR malunited* OR posttraum* OR post-
traum*).ab,ti.) AND (“Surgical Procedures, Operative”/ 
OR “debridement”/ OR osteitis/su OR osteomyelitis/su 
OR (surger* OR surgic* OR debridement*).ab,ti.) AND 
(“observational study”/ OR exp “Cohort Studies”/ OR 
“Case-Control Studies”/ OR “Cross-Sectional Studies”/ OR 
“multicenter study”/ OR “comparative study”/ OR “clini-
cal study”/ OR exp “clinical trial”/ OR “Random Alloca-
tion”/ OR exp “treatment outcome”/ OR (((observation* 
OR comparativ*) ADJ6 (stud* OR data OR research)) OR 
cohort* OR longitudinal* OR retrospectiv* OR prospectiv* 
OR ((case OR cases OR match*) ADJ3 control*) OR (cross 
ADJ section*) OR correlation* OR multicenter* OR multi-
center* OR follow-up* OR followup* OR clinical* OR trial 
OR random* OR (treatment ADJ3 (outcome* OR fail* OR 
success*))).ab,ti.) NOT (letter OR news OR comment OR 
editorial OR congresses OR abstracts).pt. AND english.la.
(B) Embase:  (‘osteitis’/de OR ‘osteomyelitis’/
de OR ‘chronic osteomyelitis’/de OR (osteitis OR 
osteomyelitis):ab,ti) AND (‘fracture’/exp OR ‘posttrau-
matic complication’/de OR (fracture* OR nonunion* OR 
malunion* OR nonunited* OR malunited* OR posttraum* 
OR post-traum*):ab,ti) AND (‘surgery’/de OR ‘surgi-
cal technique’/de OR ‘debridement’/de OR ‘osteitis’/exp/
dm_su OR (surger* OR surgic* OR debridement*):ab,ti) 
AND (‘observational study’/exp OR ‘cohort analysis’/
exp OR ‘longitudinal study’/exp OR ‘retrospective study’/
exp OR ‘prospective study’/exp OR ‘case control study’/
de OR ‘cross-sectional study’/de OR ‘correlational study’/
de OR ‘major clinical study’/de OR ‘multicenter study’/de 
OR ‘comparative study’/de OR ‘follow up’/de OR ‘clinical 
study’/de OR ‘clinical article’/de OR ‘clinical trial’/exp OR 
‘randomization’/exp OR ‘intervention study’/de OR ‘open 
study’/de OR ‘treatment outcome’/exp OR (((observation* 
OR comparativ*) NEAR/6 (stud* OR data OR research)) 
OR cohort* OR longitudinal* OR retrospectiv* OR pro-
spectiv* OR ((case OR cases OR match*) NEAR/3 control*) 
OR (cross NEXT/1 section*) OR correlation* OR multi-
center* OR multi-center* OR follow-up* OR followup* OR 
clinical* OR trial OR random* OR (treatment NEAR/3 (out-
come* OR fail* OR success*))):ab,ti) NOT ([Conference 
Abstract]/lim OR [Letter]/lim OR [Note]/lim OR [Editorial]/
lim) AND [english]/lim.
(C) Web of Science: TS=(((osteitis OR osteomyelitis)) 
AND ((fracture* OR nonunion* OR malunion* OR nonu-
nited* OR malunited* OR posttraum* OR post-traum*)) 
AND ((surger* OR surgic* OR debridement*)) AND 
((((observation* OR comparativ*) NEAR/5 (stud* OR 
data OR research)) OR cohort* OR longitudinal* OR retro-
spectiv* OR prospectiv* OR ((case OR cases OR match*) 
NEAR/2 control*) OR (cross NEAR/1 section*) OR corre-
lation* OR multicenter* OR multi-center* OR follow-up* 
OR followup* OR clinical* OR trial OR random* OR (treat-
ment NEAR/2 (outcome* OR fail* OR success*))))) AND 
DT=(article) AND LA=(english).
(D) Cochrane: ((osteitis OR osteomyelitis):ab,ti) AND 
((fracture* OR nonunion* OR malunion* OR nonunited* 
OR malunited* OR posttraum* OR post-traum*):ab,ti) AND 
((surger* OR surgic* OR debridement*):ab,ti).
(E) Google scholar:  “post traumatic | t raumatic 
osteitis|osteomyelitis” surgery|surgical|debridement all
intitle:“posttraumatic|traumatic osteitis|osteomyelitis” 
surgery|surgical|debridement
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Appendix 2: Study characteristics and quality control
References Pt (N) Pct. males 
(%)
FRI loca-
tion
Pct. tibia 
(%)
Surgical 
protocol
Type LoE MINORSa 
score
Campbell et al. [9] 12 67 T 100 CG Retrospective 
cohort
4 5b
Deng et al. [15] 15 60 T 100 CG Retrospective 
cohort
4 4b
Eralp et al. [17] 45 84 T 100 CG Retrospective 
comparison
3 11c
Hernigou et al. [22] 80 70 T 100 CG Prospective com-
parison
2 14c
Marsh et al. [26] 15 87 T 100 CG Retrospective 
comparison
3 9c
Polyzois et al. [33] 31 100 T, f 68 CG Retrospective 
cohort
4 5b
Sadek et al. [36] 16 75 T 100 CG Retrospective 
comparison
3 12c
Vitkus et al. [42] 29 – T 100 CG Retrospective 
cohort
4 3b
Wang et al. [44] 68 71 T 100 CG Retrospective 
comparison
3 11c
Chan et al. [10] 36 83 T 100 CGAB Retrospective 
cohort
4 2b
Chen et al. [11] 18 83 T 100 CGAB Retrospective 
cohort
4 5b
Eralp et al. [17] 13 69 A 0 CGAB Retrospective 
cohort
4 11c
Lin et al. [24] 16 88 T 100 CGAB Retrospective 
cohort
4 2b
Patzakis et al. [32] 33 82 T, F, U 67 CGAB Prospective cohort 4 8b
Qiu et al. [34] 18 83 T 100 CGAB Retrospective 
comparison
3 11c
Reichert et al. [35] 14 79 T, F, R, H 29 CGAB Retrospective 
cohort
4 5b
Shyam et al. [38] 7 86 F 0 CGAB Prospective com-
parison
2 14c
Zalavras et al. [49] 6 83 T 100 CGAB Retrospective 
cohort
4 6b
Jeong et al. [23] 15 67 T, A, F 47 IM Retrospective 
cohort
4 5b
Moghaddam et al. [29] 50 84 T 100 IM Prospective com-
parison
2 16c
Morris et al. [30] 12 75 T 100 IM Retrospective 
cohort
4 4b
Qiu et al. [34] 22 82 T 100 IM Retrospective 
comparison
3 11c
Scholz et al. [37] 13 92 T, f, F, R 38 IM Retrospective 
cohort
4 6b
Tong et al. [40] 20 75 T, F 65 IM Retrospective 
comparison
3 14c
Wang et al. [43] 32 69 T, F 63 IM Retrospective 
cohort
4 7b
Yu et al. [48] 13 69 F 0 IM Retrospective 
cohort
4 8b
Yang et al. [46] 51 84 T, F 92 VG Prospective cohort 4 9b
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References Pt (N) Pct. males 
(%)
FRI loca-
tion
Pct. tibia 
(%)
Surgical 
protocol
Type LoE MINORSa 
score
Doi et al. [16] 26 85 T 100 VG Retrospective 
cohort
4 3b
Erdinger et al. [21] 5 80 T 100 VG Retrospective 
cohort
3 5b
Tu and Yen [41] 240 84 T, A, F 67 VG Retrospective 
cohort
4 6b
Barbarossa et al. [8] 30 80 F 0 BT Retrospective 
cohort
4 2b
Chen et al. [12] 12 100 A 0 BT Retrospective 
cohort
4 5b
Dendrinos et al. [14] 28 82 T 100 BT Retrospective 
cohort
4 4b
Eralp et al. [19] 43 91 T 100 BT Retrospective 
comparison
3 9b
Liu et al. [25] 35 71 T 100 BT Retrospective 
cohort
4 5b
Marsh et al. [26] 10 50 T 100 BT Retrospective 
comparison
3 9c
McNally et al. [27] 18 – T 100 BT Prospective cohort 4 9c
McNally et al. [27] 16 – T 100 BT Prospective cohort 4 9c
Megas et al. [28] 9 78 T 100 BT Retrospective 
cohort
4 5b
Sadek et al. [36] 14 86 T 100 BT Retrospective 
comparison
3 12c
Shyam et al. [38] 5 100 F 0 BT Prospective com-
parison
2 14c
Tetsworth et al. [39] 21 86 T 100 BT Retrospective 
comparison
3 14c
Xu et al. [45] 30 70 T 100 BT Retrospective 
cohort
4 6b
Yin et al. [47] 100 92 T, F 65 BT Retrospective 
cohort
4 6b
Zhang et al. [50] 24 71 T 100 BT Prospective com-
parison
3 9b
Chim et al. [13] 28 75 T 100 BTAB Retrospective 
cohort
4 4b
Eralp et al. [20] 13 62 T, F 54 BTAB Retrospective 
cohort
4 5b
Eralp et al. [17] 29 69 T 100 BTAB Retrospective 
comparison
3 11c
Napora et al. [31] 75 76 T 100 BTAB Retrospective 
cohort
4 5b
Tong et al. [40] 19 79 T, F 68 BTAB Retrospective 
comparison
3 14c
LoE level of evidence, Pct. percentage, Pt patients, FRI fracture-related infection, T tibia, F femur, A ankle, f foot, U ulna, R radius, H humerus, 
CG cancellous graft, CGAB cancellous graft with local antibiotics, IM induced membrane technique, VG vascularized graft, BT bone transport, 
BTAB bone transport with local antibiotics
a Methodological Index for Non-Randomized Studies (7)
b Out of 16
c Out of 24
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Appendix 3: Funnel plots for each clinical outcome
A: Primary healing
B: Total healing
C: Recurrence of infection
D: Amputation
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Appendix 4: Forest plots for each clinical outcome, organized by treatment type
A: Primary healing
Cancellous graft
Cancellous graft with local antibiotics
Induced membrane technique
Vascularized grafts
Bone transport
Bone transport with local antibiotics
Meta-analysis
Cancellous
0,5 0,6 0,7 0,8 0,9 1,0
Proportion
Hernigou (2017)
Wang, CG (2017)
Eralp,CG (2016)
Sadek, CG (2016)
Deng (2012)
Campbel (2011)
Poluzois (2014)
Marsh, CG (1994)
Vitkus (1992)
Total (fixed effects)
Total (random effects)
Meta-analysis
cancellous + AB
0,4 0,5 0,6 0,7 0,8 0,9 1,0
Proportion
Qiu, AB (2017)
Eralp (2016)
Lin (2012)
Shyam, AB (2009)
Reichert (2007)
Chen (2005)
Zalavras (2004)
Chan (1998)
Patzakis(1993)
Total (fixed effects)
Total (random effects)
Meta-analysis
Induced Membrane
0,0 0,2 0,4 0,6 0,8 1,0
Proportion
Morris (2017)
Qiu, masq (2017)
Tong, masq (2017) 
Yu (2017)
Wang (2016)
Moghaddam, masq (2015)
Scholz (2015)
Jeong (2012)
Total (fixed effects)
Total (random effects)
Meta-analysis
Vascularized
0,4 0,5 0,6 0,7 0,8 0,9 1,0
Proportion
Yang (2012)
Tu (2007)
Erdinger (2000)
Doi (1995)
Total (fixed effects)
Total (random effects)
Meta-analysis
Bone Transport
0,0 0,2 0,4 0,6 0,8 1,0
Proportion
Zhang (2018)
McNally, BT (2017)
McNally, BT2 (2017)
Tetsworth, BT (2017)
Sadek, BT (2016)
Yin (2015)
Xu (2014)
Eralp (2012)
Liu (2012)
Chen (2010)
Megas (2009)
Shyam, BT (2009)
Barbarossa (2001)
Dendrinos (1995)
Marsh, BT (1994)
Total (fixed effects)
Total (random effects)
Meta-analysis
Bone transport + AB
0,2 0,4 0,6 0,8 1,0
Proportion
Napora (2017)
Tong, BTAB (2017) 
Eralp, BTAB (2016)
Chimm (2010)
Eralp (2007)
Total (fixed effects)
Total (random effects)
B: Total healing
Cancellous graft
Cancellous graft with local antibiotics
Induced membrane technique
Vascularized grafts
Bone transport
Bone transport with local antibiotics
Meta-analysis
Cancellous
0,6 0,7 0,8 0,9 1,0
Proportion
Hernigou (2017)
Wang, CG (2017)
Eralp,CG (2016)
Sadek, CG (2016)
Deng (2012)
Campbel (2011)
Poluzois (2014)
Marsh, CG (1994)
Vitkus (1992)
Total (fixed effects)
Total (random effects)
Meta-analysis
cancellous + AB
0,4 0,5 0,6 0,7 0,8 0,9 1,0
Proportion
Qiu, AB (2017)
Eralp (2016)
Lin (2012)
Shyam, AB (2009)
Reichert (2007)
Chen (2005)
Zalavras (2004)
Chan (1998)
Patzakis(1993)
Total (fixed effects)
Total (random effects)
Meta-analysis
Induced Membrane
0,0 0,2 0,4 0,6 0,8 1,0
Proportion
Morris (2017)
Qiu, masq (2017)
Tong, masq (2017) 
Yu (2017)
Wang (2016)
Moghaddam, masq (2015)
Scholz (2015)
Jeong (2012)
Total (fixed effects)
Total (random effects)
Meta-analysis
Vascularized
0,4 0,5 0,6 0,7 0,8 0,9 1,0
Proportion
Yang (2012)
Tu (2007)
Erdinger (2000)
Doi (1995)
Total (fixed effects)
Total (random effects)
Meta-analysis
Bone Transport
0,0 0,2 0,4 0,6 0,8 1,0
Proportion
Zhang (2018)
McNally, BT (2017)
McNally, BT2 (2017)
Tetsworth, BT (2017)
Sadek, BT (2016)
Yin (2015)
Xu (2014)
Eralp (2012)
Liu (2012)
Chen (2010)
Megas (2009)
Shyam, BT (2009)
Barbarossa (2001)
Dendrinos (1995)
Marsh, BT (1994)
Total (fixed effects)
Total (random effects)
Meta-analysis
Bone transport + AB
0,6 0,7 0,8 0,9 1,0
Proportion
Napora (2017)
Tong, BTAB (2017) 
Eralp, BTAB (2016)
Chimm (2010)
Eralp (2007)
Total (fixed effects)
Total (random effects)
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C: Recurrence of infection
Cancellous graft
Cancellous graft with local antibiotics
Induced membrane technique
Vascularized grafts
Bone transport
Bone transport with local antibiotics
Meta-analysis
Cancellous
0,0 0,1 0,2 0,3 0,4
Proportion
Hernigou (2017)
Wang, CG (2017)
Eralp,CG (2016)
Sadek, CG (2016)
Deng (2012)
Campbel (2011)
Poluzois (2014)
Marsh, CG (1994)
Vitkus (1992)
Total (fixed effects)
Total (random effects)
Meta-analysis
cancellous + AB
0,0 0,1 0,2 0,3 0,4 0,5 0,6
Proportion
Qiu, AB (2017)
Eralp (2016)
Lin (2012)
Shyam, AB (2009)
Reichert (2007)
Chen (2005)
Zalavras (2004)
Chan (1998)
Patzakis(1993)
Total (fixed effects)
Total (random effects)
Meta-analysis
Induced Membrane
0,0 0,2 0,4 0,6 0,8
Proportion
Morris (2017)
Qiu, masq (2017)
Tong, masq (2017) 
Yu (2017)
Wang (2016)
Moghaddam, masq (2015)
Scholz (2015)
Jeong (2012)
Total (fixed effects)
Total (random effects)
Meta-analysis
Vascularized
0,0 0,1 0,2 0,3 0,4 0,5 0,6
Proportion
Yang (2012)
Tu (2007)
Erdinger (2000)
Doi (1995)
Total (fixed effects)
Total (random effects)
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Bone Transport
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Yin (2015)
Xu (2014)
Eralp (2012)
Liu (2012)
Chen (2010)
Megas (2009)
Shyam, BT (2009)
Barbarossa (2001)
Dendrinos (1995)
Marsh, BT (1994)
Total (fixed effects)
Total (random effects)
Meta-analysis
Bone transport + AB
0,0 0,1 0,2 0,3 0,4 0,5
Proportion
Napora (2017)
Tong, BTAB (2017) 
Eralp, BTAB (2016)
Chimm (2010)
Eralp (2007)
Total (fixed effects)
Total (random effects)
D: Amputation
Cancellous graft
Cancellous graft with local antibiotics
Induced membrane technique
Vascularized grafts
Bone transport
Bone transport with local antibiotics
Meta-analysis
Cancellous
0,0 0,1 0,2 0,3 0,4 0,5
Proportion
Hernigou (2017)
Wang, CG (2017)
Eralp,CG (2016)
Sadek, CG (2016)
Deng (2012)
Campbel (2011)
Poluzois (2014)
Marsh, CG (1994)
Vitkus (1992)
Total (fixed effects)
Total (random effects)
Meta-analysis
cancellous + AB
0,0 0,1 0,2 0,3 0,4 0,5
Proportion
Qiu, AB (2017)
Eralp (2016)
Shyam, AB (2009)
Reichert (2007)
Chen (2005)
Zalavras (2004)
Chan (1998)
Patzakis(1993)
Total (fixed effects)
Total (random effects)
Meta-analysis
Induced Membrane
0,0 0,1 0,2 0,3 0,4 0,5
Proportion
Morris (2017)
Qiu, masq (2017)
Tong, masq (2017) 
Yu (2017)
Wang (2016)
Moghaddam, masq (2015)
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Jeong (2012)
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Marsh, BT (1994)
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Total (random effects)
Meta-analysis
Bone transport + AB
0,0 0,1 0,2 0,3
Proportion
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Tong, BTAB (2017) 
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Chimm (2010)
Eralp (2007)
Total (fixed effects)
Total (random effects)
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